Ion channel activity and associated signaling pathways are highly regulated in cancer, and TRPM8 has been proposed as a molecular target in cancer development and progression (Yee, 2015; Liu et al., 2016; Hantute-Ghesquier et al., 2018; Liu et al., 2020). This evidence concerns the gene TRPM8 and cancer.